Generation Bio Co. Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	192	109	234	403	1,319
Market Cap Growth	5.46%	-53.31%	-42.04%	-69.45%	-
Enterprise Value	66	-57	30	103	1,054
PE Ratio	-	-0.86	-1.71	-3.38	-16.38
PS Ratio	19.23	18.47	-	-	-
PB Ratio	1.45	0.54	0.83	1.06	4.92
P/FCF Ratio	-4.14	-1.81	-2.10	-4.13	-17.43
P/OCF Ratio	-4.77	-2.07	-2.28	-4.39	-18.80
EV/Sales Ratio	6.63	-9.73	-	-	-
EV/EBITDA Ratio	-0.89	0.47	-0.23	-0.90	-13.68
EV/EBIT Ratio	-0.86	0.45	-0.22	-0.86	-13.09
EV/FCF Ratio	-2.22	0.96	-0.27	-1.05	-13.94
Debt / Equity Ratio	0.73	0.48	0.29	0.21	-
Debt / EBITDA Ratio	-0.59	-0.81	-0.62	-0.71	-
Debt / FCF Ratio	-1.47	-1.63	-0.73	-0.83	-
Quick Ratio	7.82	6.72	14.89	20.25	23.56
Current Ratio	8.01	6.83	14.99	20.16	23.86
Asset Turnover	0.03	0.02	0	0	0
Return on Equity (ROE)	-82.30%	-52.30%	-43.10%	-28.40%	-43.30%
Return on Assets (ROA)	-46.70%	-31.80%	-33.30%	-24.50%	-30.10%
Return on Capital (ROIC)	-79.55%	-46.03%	-38.76%	-25.75%	-30.26%
Earnings Yield	-88.23%	-116.13%	-58.51%	-29.57%	-6.11%
FCF Yield	-34.09%	-55.16%	-47.64%	-24.24%	-5.74%
Buyback Yield / Dilution	-10.30%	-10.96%	-3.23%	-106.54%	-476.06%
Total Shareholder Return	-10.30%	-10.96%	-3.23%	-106.54%	-476.06%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).